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Abstract：BK virus （BKV） belongs to a subtype of human polyomavirus. Recessive infection rate of 
BKV in general population is about 80%. With expanded use of organ transplantation in recent years where strong 
immunosuppression is essential，BKV associated nephropathy（BKVAN），hemorrhagic cystitis，ureterostenosis 
and other associated diseases due to the reactivation of latent BKV in immunosuppressed or immunocompromised 
populations are becoming more of a concern in medical community. Since the prevention measures and effective 
antiviral drugs for BKV are rather limited，the effective means for reducing BK associated morbidity and mortality 
due to BKV associated diseases are the early monitoring of viral loads，reducing the usage of immunosuppressant，
adjusting immunosuppressant treatment regime and using adjuvant therapies. This review describes the clinical 
symptoms，biology，mechanisms and the advances in the diagnosis and treatment of BKV at home and abroad.
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在 器 官 移 植 患 者 中 ， 肾 移 植 患 者 术 后
BKV再次被激活的发生率可达10%～68%，约
1%～10%的肾移植患者会出现BKV相关肾病
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